- Home
- WHWK vs ZYXI Comparison
WHWK vs ZYXI Comparison
Compare WHWK & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHWK
- ZYXI
- Stock Information
- Founded
- WHWK 2007
- ZYXI 1996
- Country
- WHWK United States
- ZYXI United States
- Employees
- WHWK N/A
- ZYXI N/A
- Industry
- WHWK Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WHWK Health Care
- ZYXI Health Care
- Exchange
- WHWK Nasdaq
- ZYXI Nasdaq
- Market Cap
- WHWK 82.4M
- ZYXI 72.3M
- IPO Year
- WHWK N/A
- ZYXI N/A
- Fundamental
- Price
- WHWK $1.82
- ZYXI $1.49
- Analyst Decision
- WHWK
- ZYXI Hold
- Analyst Count
- WHWK 0
- ZYXI 3
- Target Price
- WHWK N/A
- ZYXI $3.00
- AVG Volume (30 Days)
- WHWK 117.1K
- ZYXI 134.9K
- Earning Date
- WHWK 08-07-2025
- ZYXI 10-23-2025
- Dividend Yield
- WHWK N/A
- ZYXI N/A
- EPS Growth
- WHWK N/A
- ZYXI N/A
- EPS
- WHWK N/A
- ZYXI N/A
- Revenue
- WHWK $21,596,000.00
- ZYXI $144,808,000.00
- Revenue This Year
- WHWK N/A
- ZYXI N/A
- Revenue Next Year
- WHWK N/A
- ZYXI $13.48
- P/E Ratio
- WHWK N/A
- ZYXI N/A
- Revenue Growth
- WHWK N/A
- ZYXI N/A
- 52 Week Low
- WHWK $1.39
- ZYXI $1.23
- 52 Week High
- WHWK $3.81
- ZYXI $9.42
- Technical
- Relative Strength Index (RSI)
- WHWK 55.63
- ZYXI 37.55
- Support Level
- WHWK $1.76
- ZYXI $1.46
- Resistance Level
- WHWK $1.87
- ZYXI $1.75
- Average True Range (ATR)
- WHWK 0.07
- ZYXI 0.10
- MACD
- WHWK 0.02
- ZYXI 0.02
- Stochastic Oscillator
- WHWK 83.33
- ZYXI 10.34
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.